Gene Regulation: From Emerging Technologies to New Models
Scientific Organizers: Michael S. Levine and L. Stirling Churchman
Date: January 23 - 26, 2022
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Transcriptional control is at the heart of developmental and disease processes. Over decades, the field gene regulation continues to elucidate how interactions between regulatory factors and elements in genomic DNA and nascent RNA control gene expression. This year, we celebrate the 40th anniversary of the enhancer, genomic DNA distal to gene promoters that controls transcription. Therapeutic strategies have struggled to target interactions between factors and cis-elements in DNA and RNA, but progress is now being made through the development of new drugs and new approaches. Furthermore, new concepts and technologies are revolutionizing our models of how transcription factors, chromatin and enhancers control genes. This meeting aims to bring together innovators developing new ways to manipulate and probe transcription, from small molecules to single cell technology, with thought leaders working to define and elucidate gene regulatory mechanisms. Participants will attend sessions on transcriptional mechanisms, from structural details to molecular condensates, gene control in development, new technologies that observe and measure transcription in single cells and a session celebrating the discovery of the enhancer. Our hope is for attendees, especially trainees, to leave the meeting excited by the field’s future and inspired by its history.
Scholarship Deadline: October 21 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
IT'S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received may still be considered for a short talk if space is available. We will accept abstracts for poster acceptance until 2 weeks prior to the meeting start date.
We gratefully acknowledge the generous grant for this conference provided by:National Human Genome Research Institute (NHGRI)
Grant No. 1R13HG012151-01
Funding for this conference was made possible (in part) by 1R13HG012151-01 from the National Human Genome Research Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.